[1] Durante C, Haddy N, Baudin E, et al.  Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy[J]. J Clin Endocrinol Metab, 2006, 91(8): 2892-2899.   doi: 10.1210/jc.2005-2838
[2] Schmid KW.  Lymph node and distant metastases of thyroid gland cancer. Metastases in the thyroid glands[J]. Pathologe, 2015, 36(Suppl 2): S171-S175.   doi: 10.1007/s00292-015-0071-6
[3] 熊延新, 张晓.  131I治疗分化型甲状腺癌骨转移疗效观察[J]. 吉林医学, 2008, 29(11): 904-906.   doi: 10.3969/j.issn.1004-0412.2008.11.014
Xiong YX, Zhang X.  Observation on the effects of radioactive iodine treatment in bone metastsis from differentiated thyroid cancer[J]. Jilin Med J, 2008, 29(11): 904-906.   doi: 10.3969/j.issn.1004-0412.2008.11.014
[4] Pittas AG, Adler M, Fazzari M, et al.  Bone metastases from thyroid carcinoma: clinical characteristics and prognostic variables in one hundred forty-six patients[J]. Thyroid, 2000, 10(3): 261-268.   doi: 10.1089/thy.2000.10.261
[5] See A, Iyer NG, Tan NC, et al.  Distant metastasis as the sole initial manifestation of well-differentiated thyroid carcinoma[J]. Eur Arch Otorhinolaryngol, 2017, 274(7): 2877-2882.   doi: 10.1007/s00405-017-4532-9
[6] Xu B, Scognamiglio T, Cohen PR, et al.  Metastatic thyroid carcinoma without identifiable primary tumor within the thyroid gland: a retrospective study of a rare phenomenon[J]. Hum Pathol, 2017, 65: 133-139.   doi: 10.1016/j.humpath.2017.05.013
[7] 许艳红, 宋红俊, 邱忠领, 等.  以骨转移为首发症状的分化型甲状腺癌的临床特征与生存分析[J]. 肿瘤, 2011, 31(6): 538-541.   doi: 10.3781/j.issn.1000-7431.2011.06.012
Xu YH, Song HJ, Qiu ZL, et al.  Differentiated thyroid carcinoma patients with bone metastasis as the initial presentation: clinical characteristics and survival analysis[J]. Tumor, 2011, 31(6): 538-541.   doi: 10.3781/j.issn.1000-7431.2011.06.012
[8] Lee J, Soh EY.  Differentiated thyroid carcinoma presenting with distant metastasis at initial diagnosis clinical outcomes and prognostic factors[J]. Ann Surg, 2010, 251(1): 114-119.   doi: 10.1097/SLA.0b013e3181b7faf6
[9] Haugen BR, Alexander EK, Bible KC, et al.  2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer[J]. Thyroid, 2016, 26(1): 1-133.   doi: 10.1089/thy.2015.0020
[10] Quan GMY, Pointillart V, Palussière J, et al.  Multidisciplinary treatment and survival of patients with vertebral metastases from thyroid carcinoma[J]. Thyroid, 2012, 22(2): 125-130.   doi: 10.1089/thy.2010.0248
[11]

董曦文, 赵戈, 王廷. 131I联合唑来膦酸治疗甲状腺癌骨转移临床研究[J/OL]. 中国医学前沿杂志(电子版), 2015, 7(4): 102−105[2019-05-21]. http://d.wanfangdata.com.cn/periodical/zgyxqyzz201504034. DOI: 10.3969/j.issn.1674-7372.2015.04.034.

Dong XW, Zhao G, Wang T. Clinical research on 131I combined zoledronic acid in treating thyroid cancer bone metastasis[J/OL]. Chinese Journal of the Frontiers of Medical Science (Electronic Version), 2015, 7(4): 102−105[2019-05-21]. http://d.wanfangdata.com.cn/periodical/zgyxqyzz201504034. DOI: 10.3969/j.issn.1674-7372.2015.04.034.
[12] 孙健雯, 宋红俊, 席闯, 等.  经皮骨水泥成形术联合131I治疗分化型甲状腺癌骨转移的疗效评价与生存分析[J]. 中华核医学与分子影像杂志, 2020, 40(6): 339-342.   doi: 10.3760/cma.j.cn321828-20200302-00082
Sun JW, Song HJ, Xi C, et al.  Efficacy evaluation of percutaneous osteoplasty combined with 131I therapy and survival analysis in patients with bone metastasis from differentiated thyroid carcinoma[J]. Chin J Nucl Med Mol Imaging, 2020, 40(6): 339-342.   doi: 10.3760/cma.j.cn321828-20200302-00082
[13] Bernier MO, Leenhardt L, Hoang C, et al.  Survival and therapeutic modalities in patients with bone metastases of differentiated thyroid carcinomas[J]. J Clin Endocrinol Metab, 2001, 86(4): 1568-1573.   doi: 10.1210/jcem.86.4.7390
[14] Schlumberger M, Challeton C, De Vathaire F, et al.  Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma[J]. J Nucl Med, 1996, 37(4): 598-605.   doi: 10.1097/00004424-199604000-00009
[15] Muresan MM, Olivier P, Leclère J, et al.  Bone metastases from differentiated thyroid carcinoma[J]. Endocr Relat Cancer, 2018, 15(1): 37-49.   doi: 10.1677/ERC-07-0229
[16] 中国临床肿瘤学会(CSCO)甲状腺癌专家委员会, 中国研究型医院学会甲状腺疾病专业委员会, 中国医师协会外科医师分会甲状腺外科医师委员会, 等.  碘难治性分化型甲状腺癌的诊治管理共识(2019年版)[J]. 中国癌症杂志, 2019, 29(6): 476-480.   doi: 10.19401/j.cnki.1007-3639.2019.06.013
Thyroid cancer expert committee of Chinese society of Clinical Oncology (CSCO), Thyroid Disease Committee of China Research Hospital Association, Thyroid surgeons Committee of surgeons branch of Chinese Medical Doctor Association, et al.  Consensus on diagnosis and management of iodine refractory differentiated thyroid cancer (2019 Edition)[J]. Chin Oncol, 2019, 29(6): 476-480.   doi: 10.19401/j.cnki.1007-3639.2019.06.013